Rare causes of hereditary breast and ovarian cancer : beyond the common suspects
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hannover, Medizinische Hochschule Hannover, Dissertation, 2021
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Medizinischen Hochschule Hannover
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Steinemann, Doris
Illig, Thomas
Dörk-Bousset, Thilo
Hannover Biomedical Research School
Institut für Humangenetik
- DOI
-
10.26068/mhhrpm/20221222-000
- URN
-
urn:nbn:de:101:1-2023050509500692021517
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bublitz, Janin
- Steinemann, Doris
- Illig, Thomas
- Dörk-Bousset, Thilo
- Hannover Biomedical Research School
- Institut für Humangenetik
- Bibliothek der Medizinischen Hochschule Hannover
Entstanden
- 2022
Ähnliche Objekte (12)
Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
Prevalence of cancer predisposition germline variants in male breast cancer patients: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
Breast and ovarian cancers in women: familial clustering, second primary cancer and cause of death
Abstracts / International Meeting on Psychosocial Aspects of Genetic Testing for Hereditary Breast and, or Ovarian Cancer (HBOC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) : the Frankfurt meeting 2001
Identifying blood-specific biomarkers for therapy-related clonal hematopoiesis in patients with hereditary or non-hereditary ovarian cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer
Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
Prevalence of cancer predisposition germline variants in male breast cancer patients: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
Breast and ovarian cancers in women: familial clustering, second primary cancer and cause of death
Abstracts / International Meeting on Psychosocial Aspects of Genetic Testing for Hereditary Breast and, or Ovarian Cancer (HBOC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) : the Frankfurt meeting 2001
Identifying blood-specific biomarkers for therapy-related clonal hematopoiesis in patients with hereditary or non-hereditary ovarian cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer
Hereditary Breast and Ovarian Cancer Service in Sparsely Populated Western Pomerania
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
Prevalence of cancer predisposition germline variants in male breast cancer patients: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
Breast and ovarian cancers in women: familial clustering, second primary cancer and cause of death
Abstracts / International Meeting on Psychosocial Aspects of Genetic Testing for Hereditary Breast and, or Ovarian Cancer (HBOC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) : the Frankfurt meeting 2001
Identifying blood-specific biomarkers for therapy-related clonal hematopoiesis in patients with hereditary or non-hereditary ovarian cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis